Introducing the MIK-EC59: Advanced (3D) Endoscopy Imaging Solution

Hikimaging is proud to introduce the MIK-EC59, a high-end 3D fluorescence camera that represents a significant advancement in the realm of (3D) endoscopy imaging. This innovative solution is designed for medical professionals seeking enhanced visualization during complex procedures. The MIK-EC59 leverages cutting-edge technology to deliver improved depth perception and clarity, crucial for effective diagnostics and surgical interventions.

Enhanced Depth Perception with (3D) Endoscopy Imaging

The MIK-EC59 utilizes the new II generation 3D fluorescence technology, enhancing depth perception by 70%. This improvement allows healthcare providers to gain a more accurate understanding of anatomical structures, particularly in challenging scenarios. The integrated binocular camera and ultra-light design make the MIK-EC59 accessible and easy to use, while the dual-channel lens enables real-time, true 3D imaging. This level of detail is essential for precise navigation during surgeries, making the MIK-EC59 an invaluable asset in any medical setting.

Compliance and Safety in 3D (ICG) Equipment

Safety and compliance are paramount in medical devices, and the MIK-EC59 adheres to stringent regulations. It meets GB9706.1-2020 and GB9706.218-2021 standards, ensuring reliability and performance in clinical environments. Additionally, its electromagnetic compatibility aligns with YY 9706.102-2021 and IEC60601-1-2:2014 standards. Such compliance underscores the commitment of Hikimaging to provide safe and effective 3D (ICG) equipment that healthcare providers can trust.

In conclusion, the MIK-EC59 is a groundbreaking solution in the field of (3D) endoscopy imaging. With its advanced fluorescence technology and commitment to safety, it enhances the capabilities of medical professionals, improving patient outcomes and procedural efficiency. Hikimaging continues to lead the way in innovative medical solutions that meet the evolving needs of the healthcare industry.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *